Epidemiological, clinical, and severity characterization of sickle cell disease in a population from the Brazilian Amazon

Hematology/Oncology and Stem Cell Therapy - Tập 12 - Trang 204-210 - 2019
Purim Cesar1, Anamika Dhyani1, Luiz Augusto Schwade1, Pollyana Acordi1, Cinthia Xerez Albuquerque1, Rejane Nina1, Erich V. De Paula1,2, Nelson Fraiji1
1Hematology and Hemotherapy Foundation from Amazonas State (HEMOAM), Manaus, AM, Brazil
2School of Medical Sciences, University of Campinas, Campinas, SP, Brazil

Tài liệu tham khảo

Piel, 2017, Sickle cell disease, N Engl J Med, 376, 1561, 10.1056/NEJMra1510865 Ware, 2017, Sickle cell disease, Lancet, 390, 311, 10.1016/S0140-6736(17)30193-9 Hounkpe, 2015, Role of innate immunity-triggered pathways in the pathogenesis of sickle cell disease: A meta-analysis of gene expression studies, Sci Rep, 5, 17822, 10.1038/srep17822 Nath, 2015, Sickle cell disease: renal manifestations and mechanisms, Nat Rev Nephrol, 11, 161, 10.1038/nrneph.2015.8 Serjeant, 2013, The natural history of sickle cell disease, Cold Spring Harb Perspect Med, 3, 10.1101/cshperspect.a011783 Elbl, 1999, The slave trade: the story of the Atlantic slave trade, 1440–1870 (review), J World Hist, 10, 473, 10.1353/jwh.1999.0005 Diniz, 2003, Educação para a genética em saúde pública : um estudo de caso sobre a anemia falciforme, Ciências e Saúde Coletiva, 10, 365, 10.1590/S1413-81232005000200014 Resque, 2016, Male lineages in Brazil: Intercontinental admixture and stratification of the European background, PLoS ONE, 11, 10.1371/journal.pone.0152573 Cançado, 2007, A doença falciforme no Brasil, Rev Bras Hematol Hemoter., 204 Da Silva, 2011, Extensive admixture in Brazilian sickle cell patients: Implications for the mapping of genetic modifiers, Blood, 118, 4493, 10.1182/blood-2011-06-361915 Durso, 2014, Association of genetic variants with self-assessed color categories in Brazilians, PLoS ONE, 9, 10.1371/journal.pone.0083926 Sebastiani, 2007, A network model to predict the risk of death in sickle cell disease, Blood, 110, 2727, 10.1182/blood-2007-04-084921 Fertrin, 2010, Genomic polymorphisms in sickle cell disease: implications for clinical diversity and treatment, Expert Rev Hematol, 3, 443, 10.1586/ehm.10.44 Grossman, 2013, Identifying recent adaptations in large-scale genomic data, Cell, 152, 703, 10.1016/j.cell.2013.01.035 Pena, 2009, DNA tests probe the genomic ancestry of Brazilians, Braz J Med Biol Res, 42, 870, 10.1590/S0100-879X2009005000026 Wang, 2015, Newborn screening for sickle cell disease: Necessary but not sufficient, J Pediatr, 91, 210, 10.1016/j.jped.2015.01.002 Martins, 2013, Self-care for the treatment of leg ulcers in sickle cell anemia: nursing guidelines, Esc Anna Nery, 17, 755, 10.5935/1414-8145.20130021 Carneiro JS, Gonçalves M de S, Albuquerque SRL, Fraiji NA, Neto JP de M. Sickle cell disease patients from the occidental Brazilian 2017;2:2–7. Ataga, 2017, Crizanlizumab for the prevention of pain crises in sickle cell disease, N Engl J Med, 376, 429, 10.1056/NEJMoa1611770 Boyd, 2006, Asthma is associated with acute chest syndrome and pain in children with sickle cell anemia, Blood, 108, 2923, 10.1182/blood-2006-01-011072 Strouse, 2011, The epidemiology, evaluation and treatment of stroke in adults with sickle cell disease, Expert Rev Hematol, 4, 597, 10.1586/ehm.11.61 Njamnshi, 2006, The epidemiology of stroke in sickle cell patients in Yaounde, Cameroon, J Neurol Sci, 250, 79, 10.1016/j.jns.2006.07.003 Belini Junior, 2015, Severity of Brazilian sickle cell disease patients: Severity scores and feasibility of the Bayesian network model use, Blood Cell Mol Dis, 54, 321, 10.1016/j.bcmd.2015.01.011 Orkin, 2019, Emerging genetic therapy for sickle cell disease, Annu Rev Med, 70, 257, 10.1146/annurev-med-041817-125507